Analysts expect Strata Critical Medical, Inc. to report revenue of 72.58 M for Q3 26, against a range of 69.17 M to 76.00 M. The most recent reported quarter, Q2 26, came in at 72.51 M, a 1.6% beat against the 71.37 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 74.88 M | 54.36 M | 54.31 M | 70.80 M | 49.30 M | 66.79 M | 67.38 M | 72.51 M | - | - | - | - |
| High Estimate | 83.20 M | 50.89 M | 55.37 M | 71.47 M | 42.36 M | 64.82 M | 69.81 M | 75.25 M | 76.00 M | 75.59 M | 78.10 M | 79.66 M |
| Low Estimate | 74.02 M | 47.06 M | 47.50 M | 61.01 M | 39.17 M | 60.39 M | 61.10 M | 67.49 M | 69.17 M | 62.97 M | 70.11 M | 66.92 M |
| Consensus Estimate | 78.61 M | 48.97 M | 51.43 M | 66.24 M | 40.77 M | 62.61 M | 65.45 M | 71.37 M | 72.58 M | 69.28 M | 74.10 M | 73.29 M |
Analysts expect Strata Critical Medical, Inc. to report earnings per share of -0.01 for Q3 26, against a range of -0.01 to -0.01. The most recent reported quarter, Q2 26, came in at -0.12, a 500.0% miss against the -0.02 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.03 | -0.13 | -0.04 | -0.05 | 0.81 | -0.06 | 0.03 | -0.12 | - | - | - | - |
| High Estimate | -0.02 | -0.11 | -0.10 | -0.04 | 0.03 | 0.01 | -0.04 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| Low Estimate | -0.02 | -0.13 | -0.12 | -0.04 | 0.03 | 0.01 | -0.04 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |
| Consensus Estimate | -0.02 | -0.12 | -0.11 | -0.04 | 0.03 | 0.01 | -0.04 | -0.02 | -0.01 | -0.01 | 0.00 | 0.00 |